Amyotrophic Lateral Sclerosis
FY25 Programmatic Panel:
Lyle Ostrow, M.D., Ph.D. (Chair)
Lewis Katz School of Medicine at Temple University
Katja Brose, Ph.D.
Consultant
Dan Elbaum, Ph.D.
QurAlis
Ernest Fraenkel, Ph.D.
MIT Department of Biological Engineering
Maj. Timothy Fullam, M.D., U.S. Air Force Retired
Barrow Neurological Institute
Molly Hammell, Ph.D.
NYU Langone Health
Moon Han, Ph.D., M.P.H., M.Sc.
Centers for Disease Control and Prevention
Matt Harms, M.D.
Columbia University
Justin Kwan, M.D.
National Institute of Neurological Disorders and Stroke, Division of Intramural Research
Joseph Lewcock, Ph.D.
Denali Therapeutics
Michael Robinson, M.D.
Healey Platform Trial Patient Advisor
Ghazaleh Sadri-Vakili, Ph.D., M.S.
Harvard Medical School
Nadia Sethi, D.D.S.
Northeast ALS Consortium Patient Education and Advocacy Committee
David Taylor, Ph.D.
ALS Society of Canada
Last updated Tuesday, January 6, 2026